Home » Topics » Regulatory » EMA

EMA
RSS

Regorafenib recommended for approval in the E.U.

July 2, 2013

European CHMP recommends approval of two infliximab biosimilars

July 2, 2013

EMA recommends approval of two GSK cancer drugs

July 2, 2013

Approval of Lemtrada for relapsing remitting MS recommended in Europe

July 2, 2013

EryDex obtains orphan drug designation for ataxia telangiectasia in Europe

June 18, 2013

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

June 10, 2013

Bavarian Nordic's smallpox vaccine receives positive opinion from CHMP

June 4, 2013

Lucentis receives positive CHMP opinion in myopic choroidal neovascularization

June 4, 2013

European CHMP recommends approval of Teva's Lonquex

June 4, 2013

CHMP recommends European approval of once-weekly somatropin

June 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...